ZA985545B - Disulfide crosslinking glycoprotein hormone analogs and their preparation and use - Google Patents

Disulfide crosslinking glycoprotein hormone analogs and their preparation and use

Info

Publication number
ZA985545B
ZA985545B ZA985545A ZA985545A ZA985545B ZA 985545 B ZA985545 B ZA 985545B ZA 985545 A ZA985545 A ZA 985545A ZA 985545 A ZA985545 A ZA 985545A ZA 985545 B ZA985545 B ZA 985545B
Authority
ZA
South Africa
Prior art keywords
preparation
hormone analogs
glycoprotein hormone
disulfide crosslinking
disulfide
Prior art date
Application number
ZA985545A
Other languages
English (en)
Inventor
William R Moyle
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21967404&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA985545(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of ZA985545B publication Critical patent/ZA985545B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA985545A 1997-06-25 1998-06-25 Disulfide crosslinking glycoprotein hormone analogs and their preparation and use ZA985545B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5078497P 1997-06-25 1997-06-25

Publications (1)

Publication Number Publication Date
ZA985545B true ZA985545B (en) 1999-04-01

Family

ID=21967404

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985545A ZA985545B (en) 1997-06-25 1998-06-25 Disulfide crosslinking glycoprotein hormone analogs and their preparation and use

Country Status (20)

Country Link
US (1) US8530190B1 (fr)
EP (2) EP0996629B1 (fr)
JP (3) JP3950484B2 (fr)
KR (2) KR100560279B1 (fr)
CN (3) CN1197968C (fr)
AR (1) AR013139A1 (fr)
AT (2) ATE335000T1 (fr)
AU (1) AU747179B2 (fr)
BR (1) BR9810478A (fr)
CA (1) CA2293731C (fr)
CY (2) CY1105763T1 (fr)
DE (2) DE69835433T2 (fr)
DK (2) DK1775346T3 (fr)
ES (2) ES2332931T3 (fr)
HU (1) HU227908B1 (fr)
IL (2) IL133686A0 (fr)
PT (2) PT996629E (fr)
SI (2) SI1775346T1 (fr)
WO (1) WO1998058957A2 (fr)
ZA (1) ZA985545B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716428B1 (en) * 1999-10-06 2004-04-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
CZ303274B6 (cs) * 2000-02-22 2012-07-11 Merck Serono Sa Zpusob vycištení luteinizacního hormonu
AU2000280019A1 (en) * 2000-10-06 2002-04-22 Regeneron Pharmaceuticals, Inc. Polypeptides, methods of making, and uses thereof
KR20040063928A (ko) * 2001-11-08 2004-07-14 윌리암 알. 모일 단백질 노브
AU2006290662B2 (en) 2005-09-14 2010-12-23 Ares Trading S.A. Method for the quantitative determination of poloxamers
PL1981908T3 (pl) * 2006-01-17 2011-04-29 Merck Serono Sa Nowe D3N warianty glikolizacji FSH
CN101250531B (zh) * 2006-11-27 2013-04-24 株式会社Lg生命科学 一核苷酸序列、包含该序列的表达载体、该载体转化的动物细胞及利用该细胞生产人fsh的方法
NZ586588A (en) 2008-02-08 2012-10-26 Biogenerix Ag Formulation of ( follice stimulating hormone) fsh and varients with benzalkonium chloride and benzyl alcohol
CN101347613B (zh) * 2008-09-17 2011-10-26 上海天伟生物制药有限公司 几乎不含亚基的糖蛋白的组合物及其制备方法
MX2011007736A (es) * 2009-01-22 2011-09-06 Novo Nordisk Healthcare Ag Compuestos de hormona del crecimiento estables.
JP5845170B2 (ja) 2009-04-01 2016-01-20 ラティオファーム ゲーエムベーハー 組換えｆｓｈを精製する方法
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2325194A1 (fr) 2009-11-24 2011-05-25 Glycotope GmbH Processus de purification de glycoprotéines
RS59459B1 (sr) 2010-01-22 2019-11-29 Novo Nordisk Healthcare Ag Hormoni rasta sa produženom in-vivo efikasnošću
MX338357B (es) 2010-01-22 2016-04-13 Novo Nordisk Healthcare Ag Compuestos estables de la hormona de crecimiento.
PL2691119T3 (pl) 2011-03-31 2019-01-31 Ferring B.V. Preparat farmaceutyczny
RU2668174C2 (ru) * 2012-07-30 2018-09-26 Трофоген Инк. Суперагонисты гликопротеинового гормона длительного действия
US11045523B2 (en) 2013-04-05 2021-06-29 Novo Nordisk Healthcare Ag Formulation of growth hormone albumin-binder conjugate
US20230365944A1 (en) * 2020-09-30 2023-11-16 The University Of North Carolina At Chapel Hill Engineered stable lactate oxidoreductases, compositions, devices, kits and uses thereof
WO2022150878A1 (fr) * 2021-01-13 2022-07-21 University Of Newcastle Compositions et procédés d'utilisation de peptides de ciblage et de nanoproduits pharmaceutiques pour la stérilisation de chats et de chiens
EP4617281A1 (fr) * 2022-11-10 2025-09-17 Kanglitai Biomedical (Qingdao) Co., Ltd. Protéine ou polypeptide hétéromère pégylé spécifique à un site, son procédé de préparation et son utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079230A (en) * 1988-09-12 1992-01-07 Pitman-Moore, Inc. Stable bioactive somatotropins
US5691455A (en) * 1995-10-24 1997-11-25 Akzo Nobel N.V. Gonadotropins with non-native disulfide bridges
US20090209453A1 (en) * 2005-04-13 2009-08-20 University Of Medicine And Dentistry Of New Jersey Glycoprotein Hormone Analogs

Also Published As

Publication number Publication date
ATE335000T1 (de) 2006-08-15
KR20040039421A (ko) 2004-05-10
CN100404551C (zh) 2008-07-23
EP1775346B1 (fr) 2009-08-12
ATE439439T1 (de) 2009-08-15
JP2007016040A (ja) 2007-01-25
WO1998058957A2 (fr) 1998-12-30
CN1197968C (zh) 2005-04-20
HU227908B1 (en) 2012-05-29
JP2001521402A (ja) 2001-11-06
DK1775346T3 (da) 2009-09-28
KR20020006720A (ko) 2002-01-26
DK0996629T3 (da) 2006-12-04
AU747179B2 (en) 2002-05-09
PT996629E (pt) 2006-12-29
JP3950484B2 (ja) 2007-08-01
WO1998058957A9 (fr) 1999-06-03
SI0996629T1 (sl) 2006-12-31
US8530190B1 (en) 2013-09-10
WO1998058957A3 (fr) 1999-04-22
KR100706469B1 (ko) 2007-04-10
AU7986198A (en) 1999-01-04
JP4279768B2 (ja) 2009-06-17
ES2332931T3 (es) 2010-02-15
DE69835433D1 (de) 2006-09-14
CY1109439T1 (el) 2014-08-13
CA2293731A1 (fr) 1998-12-30
DE69835433T2 (de) 2007-03-08
CA2293731C (fr) 2010-01-12
KR100560279B1 (ko) 2006-03-10
CN1548458A (zh) 2004-11-24
HUP0100681A3 (en) 2004-03-01
HUP0100681A1 (hu) 2001-06-28
HK1033149A1 (en) 2001-08-17
JP4278668B2 (ja) 2009-06-17
IL133686A0 (en) 2001-04-30
BR9810478A (pt) 2000-09-12
CN1269833A (zh) 2000-10-11
SI1775346T1 (sl) 2009-10-31
CN1302010C (zh) 2007-02-28
CN1548459A (zh) 2004-11-24
AR013139A1 (es) 2000-12-13
EP1775346A1 (fr) 2007-04-18
JP2005162734A (ja) 2005-06-23
PT1775346E (pt) 2009-08-25
ES2268781T3 (es) 2007-03-16
IL133686A (en) 2007-07-24
CY1105763T1 (el) 2011-02-02
EP0996629B1 (fr) 2006-08-02
EP0996629A2 (fr) 2000-05-03
DE69841063D1 (de) 2009-09-24

Similar Documents

Publication Publication Date Title
ZA985545B (en) Disulfide crosslinking glycoprotein hormone analogs and their preparation and use
HUP9900301A3 (en) Hormone patch
HUP9802603A3 (en) Lipophilic peptide hormone derivatives
HUP9904177A3 (en) Antibody against human parathormone related peptides
IL136326A0 (en) Human interferon-epsilon: a type i interferon
AU9805398A (en) Novel human egf receptors and use thereof
DE69637063D1 (de) Oral verfügbare wachstumshormon-sekretagoge
IL89869A0 (en) Bone-inducing protein
IL134596A0 (en) Growth hormone secretagogues
HRP950612B1 (en) PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
ZA959517B (en) Leutherobin and analogs thereof
GB9504761D0 (en) Amphiphilic peptide and analogs thereof
ZA96240B (en) Novel peptides their preparation and use
AU3388597A (en) Human type ii gonadotropin-releasing hormone receptor
EP0970965A4 (fr) Peptides cycliques et leur utilisation medicinale
GB9616700D0 (en) Hormone supplement
ZA9810133B (en) BMOG a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for ummonomodulatory purposes
HUP9801680A3 (en) Peptides and remedy for autoimmune diseases comprising the same
IL116658A0 (en) Peptides their preparation and use
IL113725A0 (en) Preparing recombinant aprotini and its variants
GB2336844B (en) Anti-hiv peptides and proteins
EP0915101A4 (fr) Nouveau polypeptide synthetique
AU3368289A (en) Synthetic peptides derived from the alpha-subunit of human glycoprotein hormones
HUP0102014A3 (en) Human protein c polypeptide
AU32P (en) A6520 Glycine max